Effect of F2695 on Functional Recovery After Ischemic Stroke
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy of a new serotonin-norepinephrine reuptake
inhibitor (SNRI) nin functional recovery after ischemic stroke.